![]() Partner Therapeutics Partner Therapeutics is developing and commercializing cancer medicines and combination therapies. | ![]() Agenus Agenus is a clinical-stage immuno-oncology company which focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer. | ![]() Karyopharm Therapeutics Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases. | |
Founding Date | Founding Date 2017 | Founding Date 1994 | Founding Date 2008 |
Type | Type Private | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Lexington, US HQ Boston, US Lynnwood, US | Locations Lexington, US HQ Cambridge, GB Berkeley, US New York, US | Locations Newton, US HQ München, DE Giv'atayim, IL Providence, US |
Employees | Employees 1791% increase | Employees 32812% increase | Employees 4822% decrease |
Twitter followers | Twitter followers 144 | Twitter followers 2.3 k | Twitter followers N/A |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 5 | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 3.8 | Average likes per tweet (last 30 days) 7 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 120997 | Alexa Website Rank 155568 | Alexa Website Rank 230559 |
Employee Rating | Employee Rating 4.4 | Employee Rating 3.3 | Employee Rating 3.5 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $88.2m (FY, 2020) | Revenue (est.) $108.1m (FY, 2020) |
Net income | Net income N/A | Net income ($182.9m) (FY, 2020) | Net income ($196.3m) (FY, 2020) |
Funding | |||
Total funding raised | Total funding raised $ 60m | Total funding raised $ 171.1m | Total funding raised $ 248.7m |
Agenus is a clinical-stage immuno-oncology company which focuses on the discovery and development of therapies that engage the body's immune system for patients suffering with cancer.
View companyKaryopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.
View company